000 | 01530 a2200421 4500 | ||
---|---|---|---|
005 | 20250516183409.0 | ||
264 | 0 | _c20140714 | |
008 | 201407s 0 0 eng d | ||
022 | _a1205-7541 | ||
024 | 7 |
_a10.1139/cjpp-2013-0181 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaid, Eman | |
245 | 0 | 0 |
_aModulation of thioacetamide-induced liver fibrosis/cirrhosis by sildenafil treatment. _h[electronic resource] |
260 |
_bCanadian journal of physiology and pharmacology _cDec 2013 |
||
300 |
_a1055-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCollagen _xmetabolism |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aHydroxyproline _xmetabolism |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 |
_aLiver Cirrhosis _xchemically induced |
650 | 0 | 4 |
_aLiver Cirrhosis, Experimental _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
650 | 0 | 4 |
_aPurines _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSildenafil Citrate |
650 | 0 | 4 |
_aSulfones _xadministration & dosage |
650 | 0 | 4 |
_aThioacetamide _xadverse effects |
650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xmetabolism |
700 | 1 | _aSaid, Shehta A | |
700 | 1 | _aGameil, Nariman M | |
700 | 1 | _aAmmar, Elsayed M | |
773 | 0 |
_tCanadian journal of physiology and pharmacology _gvol. 91 _gno. 12 _gp. 1055-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1139/cjpp-2013-0181 _zAvailable from publisher's website |
999 |
_c23320368 _d23320368 |